RAAVE: Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progressions of Aortic Stenosis

      -Trial Overview by Dr. Luis M. Moura et al (2007)

RABBIT II: Randomized Angioplasty Beta Blocker Intracoronary Trial II

      -Randomized Angioplasty Beta Blocker Intracoronary Trial II by Dr. Barry F. Uretsky (AHA 2006)

RACE: Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments Project

      -Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments (RACE) Project (AHA 2007)

      -A Systems Approach To Improve Survival of Patients with Myocardial Infarction In North Carolina Through Improved Application of Reperfusion Therapy by Dr. Christopher Granger

Radiation Exposure

      -Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures by Dr. Brahmajee Nallamothu

Rapamycin- and Paclitaxel-Eluting Stents With Identical Biodegradable Polymeric Coating and Design Trial

      -Trial Overview by Dr. Rainer Wessley (ACC 2006)

RAVEL: A RAndomised (double-blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™) in the treatment of patients with De Novo native coronary artery Lesions

      -A RAndomised (double-blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™) in the treatment of patients with De Novo native coronary artery Lesions by Dr. M. C. Morice

REACH: Reduction Of Atherothrombosis For Continued Health Registry

      -An International, Prospective Observational Study in Subjects at Risk of Atherothrombotic Events in an Outpatient Setting

REACT: Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial

      -Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial 6 month results by Dr. A. H. Gershlick (AHA 2004)

      -Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trial by Dr. Harindra C. Wijeysundera

REALITY: Prospective, Randomized, Multicenter Head-to-Head Comparison of Cypher and Taxus Stent Systems

      -A Prospective, Randomized, Multi-Center Comparison Study of the CYPHER Sirolimus-Eluting and TAXUS Paclitaxel-Eluting Stent Systems by Dr. Marie-Claude Morice (ACC 2005)

      -8-Month Results by Dr. Marie-Claude Morice (ACC 2005)

RELAx-AMI: Randomized Early versus Late Abciximab in Acute Myocardial Infarction treated with primary coronary intervention

      -Randomized Early versus Late Abciximab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) by Dr. Mauro Maioli

RELY: Randomized Evaluation of Long-term anticoagulant therapY

      -Dabigatran Compared to Warfarin in 18,113 Patients with Atrial Fibrillation at Risk of Stroke

RENASICA-II: El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos (National Registry of Acute Ischemic Coronary Syndromes in Mexico)

      -Right Bundle Branch Block as Risk Marker of In Hospital Mortality in ST-Elevation Acute Myocardial Infarction. A RENASICA-II Substudy by Dr. Ursulo Juarez (ESC 2007)

REPLACE-2: Randomized Evaluation Of PCI Linking Angiomax To Reduced Clinical Events

      -Elderly Patients with Major Bleeding or Need for Transfusion Complicating Percutaneous Coronary Intervention Have an Increased Risk of 30-Day and 1-Year Mortality by Dr. Michael A. Nelson (AHA 2006)

      -Eptifibatide plus Heparin Increases the Risk of Major and Minor Hemorrhagic Complications Compared to Bivalirudin in Patients with Normal Renal Function Undergoing Percutaneous Coronary Intervention by Dr. Michael C. McDaniel (AHA 2006)

RethinQ: The Resynchronization Therapy in Normal QRS Study

      -The Resynchronization Therapy in Normal QRS (RethinQ) Study by Dr. John F. Beshai (AHA 2007)

Revascularization vs Med Rx

      -The Impact of Revascularization on Mortality in Patients with Non-Acute Coronary Artery Disease by Dr. Allen Jeremias

REVERSAL: Reversing Atherosclerosis with Aggressive Lipid Lowering

      -Reversing Atherosclerosis with Aggressive Lipid Lowering by Dr. Steven E. Nissen (AHA 2003)

REVERSE: REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction

      -REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction: Results of the REVERSE Trial

RIO: Rimonabant In Overweight/Obesity

      -Rimonabant: A new approach to multiple cardiometabolic risk factors

RIO EUROPE: A Randomised Double-Blind Study of Weight Reducing Effect and Safety of Rimonabant in Obese Patients with or without Comorbidities

      -A Randomised Double-Blind Study of Weight Reducing Effect and Safety of Rimonabant in Obese Patients with or without Comorbidities by Dr. Luc Van Gaal (ACC 2005)

RIO LIPIDS: Rimonabant in Obesity

      -Rimonabant in Obesity by Dr. Jean-Pierre Despres (ACC 2004)

RUTH: Raloxifene Use For The Heart

      -Antiplatelet Therapy Use and the Risk of Venous Thromboembolic Events in the Double-Blind Raloxifene Use for the Heart (RUTH) Trial by Dr. C. Duvernoy (AHA 2007)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test